Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.47%
1,067.36
+4.96
+0.47%
—1,062.401,064.141,071.991,061.02——
SIXC
Communications
SIXC
Communications
SIXC
-0.54%
603.48
-3.26
-0.54%
—606.74606.74609.84602.33——
SIXE
Energy
SIXE
Energy
SIXE
+0.54%
1,244.93
+6.72
+0.54%
—1,238.211,236.601,247.741,232.10——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.68%
1,730.38
+11.77
+0.68%
—1,718.611,723.231,741.481,717.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.33%
639.47
+2.10
+0.33%
—637.37638.27642.30638.27——
SIXR
Staples
SIXR
Staples
SIXR
+0.16%
854.95
+1.36
+0.16%
—853.59854.05858.19851.34——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+0.11%
218.56
+0.23
+0.11%
—218.33218.33219.73217.15——
SIXT
Technology
SIXT
Technology
SIXT
+1.02%
3,631.59
+36.78
+1.02%
—3,594.813,620.103,657.473,615.34——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.80%
915.77
+7.23
+0.80%
—908.54909.50917.35907.07——
SIXV
Health care
SIXV
Health care
SIXV
+1.19%
1,512.81
+17.81
+1.19%
—1,495.001,499.611,517.101,499.61——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.41%
2,408.21
+9.90
+0.41%
—2,398.312,406.822,421.802,404.22——
DMP:FRA
Dermapharm Holding SE
€49.55
+1.43%
(+0.70) 1D
May 22, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for DMP...
Open
€49.15
High
€49.55
Low
€49.15
Mkt. cap
2.47B
Avg. vol.
106.00
Volume
100.00
Dividend
1.78%
Quarterly dividend
€0.22
Ex-dividend date
Jun 29, 2026
P/E ratio
18.50
52-wk high
€50.70
52-wk low
€31.80
EPS
€2.68
Shares outstanding
53.84M
No. of employees
4K
News stories
From sources across the web
Profile
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
About Dermapharm Holding SE
CEOHans-Georg Feldmeier
Employees3.5K
Founded1991
Headquarters-
SectorPharmaceutical industry
Websiteir.dermapharm.de
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
275.48M
297.73M
299.91M
309.10M
Cost of goods sold
91.35M
101.90M
113.32M
101.39M
Cost of revenue
91.35M
101.90M
113.32M
101.39M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
75.43M
67.31M
81.14M
78.76M
Operating expense
145.01M
135.23M
104.24M
146.89M
Total operating expenses
236.36M
237.12M
217.56M
248.28M
Operating income
39.12M
60.60M
82.35M
60.83M
Other non operating income
5.36M
5.27M
-13.11M
9.84M
EBT including unusual items
32.52M
55.16M
46.16M
61.51M
EBT excluding unusual items
32.52M
55.16M
57.48M
61.51M
Income tax expense
11.63M
14.05M
10.01M
16.38M
Effective tax rate
35.77%
25.47%
21.68%
26.63%
Other operating expenses
49.22M
46.87M
3.66M
47.74M
Net income
20.89M
41.22M
36.89M
45.20M
Net profit margin
7.58%
13.85%
12.30%
14.62%
Earnings per share
-
-
0.73
-
Interest and investment income
1.33M
5.95M
-
1.42M
Interest expense
-13.18M
-16.68M
-11.02M
-10.68M
Net interest expenses
-11.85M
-10.73M
-11.02M
-9.26M
Depreciation and amortization charges
20.36M
21.05M
19.43M
20.39M
EBITDA
59.18M
81.51M
89.38M
81.14M
Gain or loss from assets sale
-27.00K
19.00K
63.00K
90.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer